TARA Protara Therapeutics, Inc.
$2.37▲ +0.64%
Healthcare
Other
Volume 1.01M
Avg Volume (10D) 1.08M
Key Metrics & Fundamentals
Market Cap
$139.76M
P/E Ratio
–
Div Yield
0.00%
52W Range
2.28 - 7.82
% vs 50 MA
-28.92%
% vs 200 MA
-49.12%
RSI-14
30.5
MACD Histogram
+0.0200
Beta (1Y vs SPY)
1.05
Free Cash Flow
-$15.72M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$23.26M
COGS
–
Operating Exp
$23.32M
Operating Income
-$23.32M
EBIT
-$23.32M
Pretax Income
-$21.67M
Net Income
-$21.67M
EPS (Diluted)
-0.36
Price & Volume History
Loading chart…
Recent News
Protara Therapeutics Completes Enrollment of the Phase 2b Open-Label Dose Confirmation Phase of the THRIVE-3 Registrational Trial of IV Choline Chloride in Patients on Parenteral Support
GlobeNewswire · Oct 15, 2026 8:00 AM ET
Protara Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 8, 2026 4:05 PM ET
Protara Therapeutics: Q2 Earnings Snapshot
Associated Press · Aug 11, 2026 8:11 AM ET
Protara Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business Update
GlobeNewswire · Aug 11, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See TARA's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.